Hepatitis C Update: A Growing Challenge With Evolving Management Solutions
  • CME

In this updated CME-certified interactive presentation targeted to primary care clinicians, hepatitis expert Terry D. Box, MD, reviews the changing epidemiology of hepatitis C infections, age- and risk-based HCV screening, follow-up after testing in the primary care and specialist settings, and counseling patients on the benefits of HCV screening and treatment.
Terry D. Box, MD
Brian L. Pearlman, MD, FACP, FAASLD
Mary Speigle, NP
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
Released: January 17, 2018 Expiration: January 16, 2019
Multimedia Hepatitis C Update: A Growing Challenge With Evolving Management Solutions
This program is divided into short segments. After reviewing all segments, click the Claim Credit button to complete the CME posttest and evaluation.
Part 1: Introduction
Terry D. Box, MD, reviews the evolution of HCV treatment and recent epidemiological changes in HCV infections.
Launch Part 1: Introduction
Part 2: When and How to Screen for Hepatitis C Virus Infection (5 minutes)
Listen to age-based and risk-based approaches for HCV screening.
Launch Part 2: When and How to Screen for Hepatitis C Virus Infection (5 minutes)
Part 3: Follow-up After Initial HCV Screening (8 minutes)
Review guidance on counseling strategies and fibrosis staging for HCV-infected patients.
Launch Part 3: Follow-up After Initial HCV Screening (8 minutes)
Part 4: Ongoing Management of Hepatitis C Infection in Primary Care (8 minutes)
Learn about optimizing treatment in the primary care setting and when to refer HCV-infected patients to specialist care.
Launch Part 4: Ongoing Management of Hepatitis C Infection in Primary Care (8 minutes)
Part 5: Hepatitis C Treatment Considerations (8 minutes)
Listen to key considerations on individualizing treatment for each HCV-infected patient.
Launch Part 5: Hepatitis C Treatment Considerations (8 minutes)
Part 6: Post-treatment Follow-up and Key Summary Points (4 minutes)
Review key strategies for determining when your HCV-infected patients are cured and/or need specialist follow-up.
Launch Part 6: Post-treatment Follow-up and Key Summary Points (4 minutes)

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply current guidelines on age-cohort and risk-based HCV screening
  • Appropriately manage newly diagnosed and other untreated HCV patients, including staging and counseling them regarding the multiple health consequences of HCV infection
  • Accurately counsel patients regarding current HCV treatment options, including recommended timing of treatment and key characteristics of current regimens
  • Appropriately distinguish between HCV-infected patients who can be managed in primary care vs those requiring linkage to specialist care

Acknowledgements

Jointly provided by Primary Care Network and Clinical Care Options, LLC

Primary Care Network
2131 West Republic Road #206
Springfield, MO 65807

Jill Hays, CHCP, Executive Director
education@primarycarenetwork.org
www.primarycarenetwork.org
www.pimed.com

Educational grant provided by:
Gilead Sciences

Information on this Educational Activity

STATEMENT OF DISCLOSURE AND INDEPENDENCE

It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.

PCN’s Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentation are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity’s commercial supporter(s).

REVIEW COMMITTEE DISCLOSURES
In accordance with PCN policy, all content is reviewed by independent peer reviewers for balance, objectivity, and commercial bias.

It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.

PCN’s Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

Faculty

Terry D. Box, MD

Associate Professor of Medicine
Division for Gastroenterology, Hepatology, Nutrition
University of Utah
Salt Lake City, Utah

Terry D. Box, MD, has disclosed that he has served on advisory boards for AbbVie, Bayer, Gilead Sciences, and Intercept; has received funds for research support from Gilead Sciences and Merck; and has served on speaker bureaus for Gilead Sciences.
Brian L. Pearlman, MD, FACP, FAASLD

Medical Director, Center for Hepatitis C
Wellstar Atlanta Medical Center
Atlanta, Georgia
Professor of Medicine
Medical College of Georgia
Augusta, Georgia
Associate Professor of Medicine
Emory School of Medicine
Atlanta, Georgia

Brian Pearlman, MD, has disclosed that he has served on advisory boards for Merck; has received funds for research support from AbbVie, Gilead Sciences, and Merck; and has served on speaker bureaus for AbbVie, Gilead Sciences, and Merck.
Mary Speigle, NP

Nurse Practitioner
Shasta Community Health Center
Redding, California

Mary Speigle, NP, has no relevant financial relationships to disclose.

Staff

Megan Cartwright, PhD

Clinical Editor

Megan Cartwright, PhD, has no relevant financial relationships to disclose.
Cindy Fisher

CME Program Manager, PCN
Springfield, Missouri

Cindy Fisher has no relevant financial relationships to disclose.
Jill Hays, CHCP

PCN Content Reviewer
Executive Director
Primary Care Network
Springfield, Missouri

Jill Hays, CHCP, has no relevant financial relationships to disclose.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant financial relationships to disclose.
Brian Koffman, MDCM

PCN Content Reviewer
Medical Director, CLL Society Inc.
Partner, St Jude Heritage Medical Group
Diamond Bar, California
Clinical Professor (Retired)
Department of Family Medicine
Keck School of Medicine, USC Family Practice
Los Angeles, California

Consultant: Ironwood, Janssen Pharmaceuticals, Inc. Stockholder: AbbVie, AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Mei Pharma, Sunesis, Verastem
Jenny Schulz, PhD

Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no relevant financial relationships to disclose.
Zachary Schwartz, MSc, ELS

Managing Editor

Zachary Schwartz, MSc, ELS, has no relevant financial relationships to disclose.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards or consultants.

Target Audience

This program is intended for internists, family physicians, nurse practitioners and physician assistants.

Goal

The goal of this activity is to improve primary care clinicians’ competence in the diagnosis and management of uncomplicated chronic hepatitis C infection.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and Clinical Care Options. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Primary Care Network designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 17, 2018, through January 16, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?